{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-026592","form_type":"8-K","ticker":"NTRA","cik":"0001604821","company_name":"Natera, Inc.","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.331544+00:00","generated_at":"2026-06-27T04:49:56.053422+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Natera Q4 revenue $173M (+54% YoY); net loss widens to $140.6M; FY 2022 guidance $770-790M","bullets":["Q4 2021 revenue $173.0M (+53.9% YoY); full year 2021 revenue $625.5M (+60% YoY), exceeding prior guidance.","Q4 net loss $140.6M ($1.48/share) vs $76.4M loss ($0.89/share) in Q4 2020; FY 2021 net loss $471.7M ($5.21/share).","Processed ~438,800 tests in Q4 (+48.7% YoY); full year ~1,570,000 tests processed.","FY 2022 guidance: revenue $770M-$790M; gross margin ~46%-48%; SG&A $560M-$590M; R&D $340M-$360M; net cash consumption $370M-$400M.","Received CMS coverage for Signatera pan-cancer monitoring; presented positive data from Trifecta and CIRCULATE-Japan studies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-026592","json":"https://secwatch.observer/filing/0001104659-22-026592.json","markdown":"https://secwatch.observer/filing/0001104659-22-026592.md","text":"https://secwatch.observer/filing/0001104659-22-026592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604821/000110465922026592/0001104659-22-026592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604821/000110465922026592/tm227574d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:49:56.053422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}